New study aims to speed up leishmaniasis diagnosis in kids

NCT ID NCT07504757

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tracks 200 children in Italy with leishmaniasis, a parasitic infection that can affect the skin or internal organs. Researchers will look at how quickly the disease is diagnosed and treated, and how that affects recovery, relapse, and death rates. The goal is to identify delays and improve care for children with this condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors diagnose and treat leishmaniasis in children faster, reducing complications and relapses.

What could go wrong

This is an observational study, not a treatment trial. It collects data but does not test a new drug or intervention, so direct patient benefits are not guaranteed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEISHMANIA INFANTUM DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous leishmaniasis mucocutaneous leishmaniasis visceral leishmaniasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AOU Meyer IRCCS

    RECRUITING

    Florence, Tuscany, 50139, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••